211 related articles for article (PubMed ID: 7237955)
1. [Thyrocalcitonin, betamethasone and hydration in hypercalcemia caused by bone metastases of breast carcinoma].
Azzoini P
Clin Ter; 1981 Apr; 97(2):147-52. PubMed ID: 7237955
[No Abstract] [Full Text] [Related]
2. [Thyrocalcitonin: therapeutic confirmation in neoplastic hypercalcemia].
Azzoni P; Turco P; Dal Negro R; Govoni P
Clin Ter; 1977 Sep; 82(5):483-8. PubMed ID: 923189
[No Abstract] [Full Text] [Related]
3. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
Simone C; Racanelli A
Clin Ter; 1981 Aug; 98(3):247-67. PubMed ID: 7285537
[No Abstract] [Full Text] [Related]
4. The treatment of hypercalcemia associated with metastases to bone from primary breast cancer.
Ariel IM; Kempner R
Bull Hosp Jt Dis Orthop Inst; 1988; 48(1):82-7. PubMed ID: 2840153
[TBL] [Abstract][Full Text] [Related]
5. [Update on paraneoplastic hypercalcemia. Our experience in the treatment of hypercalcemic states of patients with advanced breast carcinoma].
Grottolo A; Ferrari V; Lazzari R; Mariano MR; Zambruni A; Zaniboni A
Minerva Med; 1988 Jul; 79(7):527-31. PubMed ID: 3405454
[TBL] [Abstract][Full Text] [Related]
6. [Results of thyrocalcitonin mithramycin, and indomethacin treatment of a case of hypercalcemia in tumor of the lung].
Pesce L; Del Torre L; Busolin G; Macaluso S
Arch Monaldi; 1977; 31(2):119-31. PubMed ID: 141246
[No Abstract] [Full Text] [Related]
7. Synthetic human calcitonin in the treatment of hypercalcaemia of metastatic breast cancer: preliminary report.
Koelmeyer TD; Stephens EJ
N Z Med J; 1978 Jun; 87(614):434-5. PubMed ID: 277810
[No Abstract] [Full Text] [Related]
8. [Hypercalcemia in breast cancer].
Okada Y; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Ikeda K; Usui N; Nakada H; Adachi K; Mukaiyama T
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1468-74. PubMed ID: 6742868
[TBL] [Abstract][Full Text] [Related]
9. [Results of using Aredia for hypercalcemia in oncology patients].
Lichinitser MR; Vyshinskaia GV; Kupchan DZ; Liubimova NV
Ter Arkh; 1993; 65(9):80-1. PubMed ID: 8303606
[No Abstract] [Full Text] [Related]
10. Proceedings: Hypercalcemia in patients with malignant diseases and treatment with porcine calcitonin.
Abe K; Adachi I
Calcif Tissue Res; 1974; 15(2):153-4. PubMed ID: 4844388
[No Abstract] [Full Text] [Related]
11. [Analysis of 18 breast cancer patients with hypercalcemia].
Masuda N; Yayoi E; Furukawa J; Maruhashi S; Tokunaga M; Takiguchi S; Matsui S; Yano H; Tateishi H; Kinuta M; Maruyama H; Okamura J
Gan To Kagaku Ryoho; 1998 May; 25(6):845-51. PubMed ID: 9617323
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hypercalcemias].
Courvoisier B
Schweiz Med Wochenschr; 1981 Dec; 111(49):1876-8. PubMed ID: 6800027
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of malignancy-associated hypercalcemia from bone metastases of breast cancer successfully treated with combination therapy using pamidronate and calcitonin].
Kusama M; Kaise H; Nakayama S; Ota D; Aoki T; Koyanagi Y; Matsunaga T; Nakamura Y
Gan To Kagaku Ryoho; 2000 May; 27(5):763-6. PubMed ID: 10832449
[TBL] [Abstract][Full Text] [Related]
14. [Effects of synthetic eel calcitonin on hypercalcemia--with special reference to its acute effect].
Sakai T; Suzuki J; Marushige F
Horumon To Rinsho; 1979 Jan; 27(1):71-6. PubMed ID: 284873
[No Abstract] [Full Text] [Related]
15. Proceedings: Hypercalcemia in malignant bone diseases and its management. Studies on calcium metabolism and the use of calcitonin.
Takatsuki K; Yodoi J; Wakisaka G; Yamamoto I; Hamamoto K
Calcif Tissue Res; 1974; 15(2):157. PubMed ID: 4844394
[No Abstract] [Full Text] [Related]
16. Hypercalcemia of malignancy: pathophysiology and implications for treatment.
Theriault RL
Oncology (Williston Park); 1993 Jan; 7(1):47-50; discussion 52-5. PubMed ID: 8420542
[TBL] [Abstract][Full Text] [Related]
17. [Severe hypercalcemia: response to treatment].
Pérez C; Alvarez M; Pérez I; Arriagada D
Rev Med Chil; 1988 Nov; 116(11):1124-7. PubMed ID: 3267897
[No Abstract] [Full Text] [Related]
18. Malignant hypercalcemia: treatment with thyrocalcitonin and mithramycin.
Adams JS; Hartman CR
J Kans Med Soc; 1977 Feb; 78(2):63-4, 78. PubMed ID: 138711
[No Abstract] [Full Text] [Related]
19. [Therapeutic indications for calcitonin. Experimental examination in some pathologic conditions].
Perraro F; Piccini F; Donati E
Folia Endocrinol; 1972 Oct; 25(5):411-23. PubMed ID: 4679243
[No Abstract] [Full Text] [Related]
20. Malignant hypercalcemia--a hospital survey.
Blomqvist CP
Acta Med Scand; 1986; 220(5):455-63. PubMed ID: 3812029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
